While more studies are required, PGLYRP1 certainly modulates the tumour immune cell composition and may play a previously unrecognised role in altering immune cell behaviour, promoting their protumoural characteristics and influencing their survival. This evidence concerns the gene PGLYRP1 and neoplasm.